Authors

• Kazuki Tanimoto (ORCID: https://orcid.org/0000-0002-5299-8867)
• Naoyuki Uchida (ORCID: https://orcid.org/0000-0001-5952-5926)
• Atsushi Wake (ORCID: https://orcid.org/0000-0002-9653-6170)
• Koji Nagafuji (ORCID: https://orcid.org/0000-0003-4795-121X)
• Tomoaki Fujisaki
• Toshiro Kurokawa
• Koji Kato (ORCID: https://orcid.org/0000-0002-5815-4585)
• Tomohiko Kamimura
• Toshihiro Miyamoto (ORCID: https://orcid.org/0000-0002-6533-1594)
• Kentaro Kohno
• Koji Yonemoto (ORCID: https://orcid.org/0000-0002-9712-1057)
• Ken Takase
• Junichi Tsukada (ORCID: https://orcid.org/0000-0003-1905-0668)
• Yutaka Imamura (ORCID: https://orcid.org/0000-0003-4296-3457)
• Koichi Akashi (ORCID: https://orcid.org/0000-0001-7763-5723)
• Yasuhiko Miyazaki
• Yoshikiyo Ito
• Tetsuya Eto
• Yukio Kondo
• Noriaki Kawano

Institutions

• Kanazawa University (JP)
• Kurume University (JP)
• University of Occupational and Environmental Health Japan (JP)
• National Kyushu Medical Center (JP)
• University of the Ryukyus (JP)
• Toyama Prefectural Central Hospital (JP)
• St Mary's Hospital (JP)
• Kyushu University Hospital (JP)
• Hamanomachi Hospital (JP)
• Miyazaki Prefectural Hospital (JP)
• Japanese Red Cross Fukuoka Hospital (JP)
• Kyushu Hospital (JP)
• Oita Prefectural Hospital (JP)
• Matsuyama Red Cross Hospital (JP)
• Imamura Hospital (JP)
• Harasanshin Hospital (JP)
• Toranomon Hospital (JP)

Publication Details

Journal

European Journal Of Haematology

Published

2025-03-07

DOI

https://doi.org/10.1111/ejh.14407

Primary Topic

Chronic Myeloid Leukemia Treatments

Type

article

Field-Weighted Citation Impact

0.00